Browse by author
Lookup NU author(s): Emeritus Professor Nick Europe-Finner
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The development of targeted therapies for pulmonary arterial hypertension currently based on prostaglandin, nitric oxide, and endothelin pathways has resulted in major advances in the treatment of patients with pulmonary arterial hypertension. This article reviews the current evidence that supports both the use of mono- and combination therapy. The article also considers the role of atrial septostomy in the treatment of pulmonary arterial hypertension, particularly as a bridge to transplantation. Finally, the article provides a review of the role and outcomes of pulmonary thromboendartertectomy for patients with chronic thromboennbolic pulmonary hypertension.
Author(s): Corris PA
Publication type: Article
Publication status: Published
Journal: Clinics in Chest Medicine
Year: 2011
Volume: 32
Issue: 2
Pages: 399-410
Print publication date: 19/04/2011
ISSN (print): 0272-5231
ISSN (electronic): 1557-8216
Publisher: WB Saunders Co.
URL: http://dx.doi.org/10.1016/j.ccm.2011.02.015
DOI: 10.1016/j.ccm.2011.02.015
Altmetrics provided by Altmetric